| ||
| In the Literature: Physician Reviews of HM-Related Research The Hospitalist Online Clinical question: Can lebrikizumab, an IL-13 antibody, improve asthma control in patients with uncontrolled asthma? Background: Asthma is a complex disease, with varied patient response to treatment. Some patients have uncontrolled asthma despite ... See all stories on this topic » |
This once a week Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment